The upcoming reports and webinars listed below are provided as part of the Centre’s support for EU Business in Japan. This section provides valuable information for European Union companies seeking clear guidelines for trading, investing, or partnering with Japanese entities. Please note that access to this content is restricted to registered members only. Free membership, register here.
Chemical Industry in Japan with a Focus on PFAS
Japan is actively addressing the contamination of Per- and Polyfluoroalkyl Substances (PFAS) in its water, air, soil and broader environment, with a ban of 138 PFAS (PFOA-related substances) taking effect on 10th January 2025. Japan’s regulatory shift to safer and more sustainable alternatives presents strategic business opportunities for European companies to develop and offer PFAS-free technologies. This strengthens their position in the growing market for chemical safety solutions and environmentally sustainable industrial practices. This report explores the recent market and technology trends in Japan’s chemical industry, with a focus on PFAS, highlighting opportunities and recommendations for European companies doing business in Japan or planning to enter the Japanese market.
Japan's Quantum Technology Sector
Japan is making significant strides in quantum computing, communication, cryptography, and sensing, driven by substantial government investment and strategic initiatives. This report identifies specific opportunities for EU companies in Japan within areas such as quantum computing, communication, sensing, and materials. For EU firms specialising in quantum software and algorithms, Japan has considerable demand for solutions applicable to the automotive, finance, and healthcare industries. Japan’s emphasis on cybersecurity and secure communication infrastructure further opens market opportunities in quantum cryptography and secure communications.
How to Export to Japan (Medical Devices) - Quick Guide 2025
The EU is one of the largest global producers of medical devices, and the biggest exporter with a trade surplus of 11 billion EUR in 2023. Japan is an essential trade partner ranking 3rd within the main destination countries of EU exports according to MedTech Europe. EU manufacturers need to consider important market drivers when targeting Japan, such as the rapidly aging demography, the growing prevalence of chronic diseases due to changes in lifestyle, and the high reliance of the local market to imports. This guide aims to provide a brief overview on aspects to be considered when exporting medical devices to Japan.
Find these events and more on our events website.
The EU-Japan Centre currently produces 5 newsletters :
Joint venture established in 1987 by the European Commission (DG GROW) and the Japanese Government (METI) for promoting all forms of industrial, trade and investment cooperation between the EU and Japan.
The EU-Japan Centre’s activities are subject to the allocation of a Grant Agreement by the European Commission for 2024-2026
You are now accessing a members only part of our website available to EU companies only.
Please create an account (or login) to access information, reports and webinars about Japan.